Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis | Zendy

William Bowie | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis

Author(s) -

William Bowie

Publication year - 1982

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.21.2.339

Subject(s) - cefoxitin , cefamandole , cefuroxime , chlamydia trachomatis , piperacillin , cephalosporin , microbiology and biotechnology , medicine , in vitro , antibiotics , virology , biology , bacteria , pseudomonas aeruginosa , staphylococcus aureus , genetics , biochemistry

Newer penicillins and cephalosporins are being evaluated in many infections. One of these infections, acute pelvic inflammatory disease, can be caused by Chlamydia trachomatis. This study demonstrated that cefoxitin, cefamandole, cefuroxime, and piperacillin had no effective in vitro activity against C. trachomatis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research